Guter Newsflow die letzten Wochen bei $ROG (+0,46 %)
https://pmlive.com/pharma_news/roches-itovebi-combination-granted-fda-approval-for-advanced-breast-cancer/
2Mon.·
pmlive.comRoche’s Itovebi combination granted FDA approval for advanced breast cancer - PMLiVE
1